Holt S et al. |
Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacin. |
2007 |
Eur. J. Pharmacol. |
pmid:17397826
|
Rodella LF et al. |
AM404, an inhibitor of anandamide reuptake decreases Fos-immunoreactivity in the spinal cord of neuropathic rats after non-noxious stimulation. |
2005 |
Eur. J. Pharmacol. |
pmid:15680264
|
Peroni RN et al. |
Sex-linked differences in the vasorelaxant effects of anandamide in vascular mesenteric beds: role of oestrogens. |
2004 |
Eur. J. Pharmacol. |
pmid:15189776
|
Wheal AJ and Randall MD |
Effects of hypertension on vasorelaxation to endocannabinoids in vitro. |
2009 |
Eur. J. Pharmacol. |
pmid:19100733
|
Beltramo M and Piomelli D |
Anandamide transport inhibition by the vanilloid agonist olvanil. |
1999 |
Eur. J. Pharmacol. |
pmid:9920187
|
Stengel PW et al. |
Pulmonary actions of anandamide, an endogenous cannabinoid receptor agonist, in guinea pigs. |
1998 |
Eur. J. Pharmacol. |
pmid:9754939
|
Vann RE et al. |
Discriminative stimulus properties of delta9-tetrahydrocannabinol (THC) in C57Bl/6J mice. |
2009 |
Eur. J. Pharmacol. |
pmid:19470387
|
Ralevic V et al. |
Cannabinoid activation of recombinant and endogenous vanilloid receptors. |
2001 |
Eur. J. Pharmacol. |
pmid:11672565
|
Wallace MJ et al. |
Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity. |
2002 |
Eur. J. Pharmacol. |
pmid:12359270
|
Kelley BG and Thayer SA |
Anandamide transport inhibitor AM404 and structurally related compounds inhibit synaptic transmission between rat hippocampal neurons in culture independent of cannabinoid CB1 receptors. |
2004 |
Eur. J. Pharmacol. |
pmid:15288572
|
O'Sullivan SE et al. |
Vascular effects of delta 9-tetrahydrocannabinol (THC), anandamide and N-arachidonoyldopamine (NADA) in the rat isolated aorta. |
2005 |
Eur. J. Pharmacol. |
pmid:15659311
|
Del Arco I et al. |
Attenuation of spontaneous opiate withdrawal in mice by the anandamide transport inhibitor AM404. |
2002 |
Eur. J. Pharmacol. |
pmid:12409011
|
Wagner JA et al. |
Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors. |
2001 |
Eur. J. Pharmacol. |
pmid:11448486
|
Orliac ML et al. |
Increases in vanilloid TRPV1 receptor protein and CGRP content during endotoxemia in rats. |
2007 |
Eur. J. Pharmacol. |
pmid:17482593
|
Wheal AJ et al. |
Hydrogen peroxide as a mediator of vasorelaxation evoked by N-oleoylethanolamine and anandamide in rat small mesenteric arteries. |
2012 |
Eur. J. Pharmacol. |
pmid:22154756
|
Bouaboula M et al. |
Anandamide induced PPARgamma transcriptional activation and 3T3-L1 preadipocyte differentiation. |
2005 |
Eur. J. Pharmacol. |
pmid:15987634
|
Nilsson O et al. |
The cannabinoid agonist WIN 55,212-2 inhibits TNF-alpha-induced neutrophil transmigration across ECV304 cells. |
2006 |
Eur. J. Pharmacol. |
pmid:16928371
|
McQueen DS et al. |
Cannabidiol lacks the vanilloid VR1-mediated vasorespiratory effects of capsaicin and anandamide in anaesthetised rats. |
2004 |
Eur. J. Pharmacol. |
pmid:15140635
|
Fowler CJ et al. |
Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis--a difficult issue to handle. |
2004 |
Eur. J. Pharmacol. |
pmid:15145699
|
Romano MR and Lograno MD |
Involvement of the peroxisome proliferator-activated receptor (PPAR) alpha in vascular response of endocannabinoids in the bovine ophthalmic artery. |
2012 |
Eur. J. Pharmacol. |
pmid:22429572
|
Wiley JL et al. |
Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodents. |
2014 |
Eur. J. Pharmacol. |
pmid:24858366
|
Mendizábal VE et al. |
Long-term inhibition of nitric oxide synthase potentiates effects of anandamide in the rat mesenteric bed. |
2001 |
Eur. J. Pharmacol. |
pmid:11567656
|
Bermúdez-Siva FJ et al. |
Activation of cannabinoid CB1 receptors induces glucose intolerance in rats. |
2006 |
Eur. J. Pharmacol. |
pmid:16423347
|
Shimasue K et al. |
Effects of anandamide and arachidonic acid on specific binding of (+) -PN200-110, diltiazem and (-) -desmethoxyverapamil to L-type Ca2+ channel. |
1996 |
Eur. J. Pharmacol. |
pmid:8904088
|
de Lago E et al. |
In vivo pharmacological actions of two novel inhibitors of anandamide cellular uptake. |
2004 |
Eur. J. Pharmacol. |
pmid:14744610
|
GarcÃa Mdel C et al. |
Role of CGRP and GABA in the hypotensive effect of intrathecally administered anandamide to anesthetized rats. |
2006 |
Eur. J. Pharmacol. |
pmid:16472800
|
Moezi L et al. |
Potentiation of anandamide effects in mesenteric beds isolated from bile duct-ligated rats: role of nitric oxide. |
2004 |
Eur. J. Pharmacol. |
pmid:14751408
|
Wiley J et al. |
Discriminative stimulus effects of anandamide in rats. |
1995 |
Eur. J. Pharmacol. |
pmid:7781695
|
Wickens AP and Pertwee RG |
delta 9-Tetrahydrocannabinol and anandamide enhance the ability of muscimol to induce catalepsy in the globus pallidus of rats. |
1993 |
Eur. J. Pharmacol. |
pmid:8119321
|
Bondarenko AI et al. |
Direct activation of Ca and voltage-gated potassium channels of large conductance by anandamide in endothelial cells does not support the presence of endothelial atypical cannabinoid receptor. |
2017 |
Eur. J. Pharmacol. |
pmid:28327344
|
Pelorosso FG et al. |
The endocannabinoid anandamide inhibits kinin B1 receptor sensitization through cannabinoid CB1 receptor stimulation in human umbilical vein. |
2009 |
Eur. J. Pharmacol. |
pmid:19022239
|
Jackson SN et al. |
Volatile anesthetics and endogenous cannabinoid anandamide have additive and independent inhibitory effects on alpha(7)-nicotinic acetylcholine receptor-mediated responses in Xenopus oocytes. |
2008 |
Eur. J. Pharmacol. |
pmid:18242598
|
Walentiny DM et al. |
The endogenous cannabinoid anandamide shares discriminative stimulus effects with ∆(9)-tetrahydrocannabinol in fatty acid amide hydrolase knockout mice. |
2011 |
Eur. J. Pharmacol. |
pmid:21300050
|
Baldassano S et al. |
Cannabinoid CB(1) receptor activation modulates spontaneous contractile activity in mouse ileal longitudinal muscle. |
2008 |
Eur. J. Pharmacol. |
pmid:18234188
|
Lau AH and Chow SS |
Effects of cannabinoid receptor agonists on immunologically induced histamine release from rat peritoneal mast cells. |
2003 |
Eur. J. Pharmacol. |
pmid:12620517
|
GarcÃa Mdel C et al. |
Impaired hypotensive responses induced by intrathecally injected drugs in fructose-fed rats. |
2013 |
Eur. J. Pharmacol. |
pmid:23499700
|
Peroni RN et al. |
Participation of CGRP and prostanoids in the sex-linked differences of vascular anandamide effects in mesenteric beds of Sprague-Dawley rats. |
2007 |
Eur. J. Pharmacol. |
pmid:17169358
|
Russo R et al. |
Synergistic antinociception by the cannabinoid receptor agonist anandamide and the PPAR-alpha receptor agonist GW7647. |
2007 |
Eur. J. Pharmacol. |
pmid:17434479
|
Romano MR and Lograno MD |
Signaling cross-talk between cannabinoid and muscarinic systems actives Rho-kinase and increases the contractile responses of the bovine ciliary muscle. |
2013 |
Eur. J. Pharmacol. |
pmid:23396229
|
Barg J et al. |
Cannabinomimetic behavioral effects of and adenylate cyclase inhibition by two new endogenous anandamides. |
1995 |
Eur. J. Pharmacol. |
pmid:8749028
|
Gifford AN et al. |
Potentiation of the action of anandamide on hippocampal slices by the fatty acid amide hydrolase inhibitor, palmitylsulphonyl fluoride (AM 374). |
1999 |
Eur. J. Pharmacol. |
pmid:10556675
|
Stamer WD et al. |
Cannabinoid CB(1) receptor expression, activation and detection of endogenous ligand in trabecular meshwork and ciliary process tissues. |
2001 |
Eur. J. Pharmacol. |
pmid:11730719
|
Zygmunt PM et al. |
The anandamide transport inhibitor AM404 activates vanilloid receptors. |
2000 |
Eur. J. Pharmacol. |
pmid:10822052
|
Wiley JL et al. |
Task specificity of cross-tolerance between Delta9-tetrahydrocannabinol and anandamide analogs in mice. |
2005 |
Eur. J. Pharmacol. |
pmid:15740725
|
Zaniewska M et al. |
Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in rats. |
2006 |
Eur. J. Pharmacol. |
pmid:16730696
|
Stella N and Piomelli D |
Receptor-dependent formation of endogenous cannabinoids in cortical neurons. |
2001 |
Eur. J. Pharmacol. |
pmid:11513837
|
Costa B and Colleoni M |
Changes in rat brain energetic metabolism after exposure to anandamide or Delta(9)-tetrahydrocannabinol. |
2000 |
Eur. J. Pharmacol. |
pmid:10781666
|
Varga K et al. |
Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide. |
1995 |
Eur. J. Pharmacol. |
pmid:7589169
|
Alptekin A et al. |
The effects of anandamide transport inhibitor AM404 on voltage-dependent calcium channels. |
2010 |
Eur. J. Pharmacol. |
pmid:20171208
|
Randall MD et al. |
Comparative pharmacology of endothelium-derived hyperpolarizing factor and anandamide in rat isolated mesentery. |
1997 |
Eur. J. Pharmacol. |
pmid:9314035
|
Randall MD and Kendall DA |
Involvement of a cannabinoid in endothelium-derived hyperpolarizing factor-mediated coronary vasorelaxation. |
1997 |
Eur. J. Pharmacol. |
pmid:9369375
|
Burkey TH et al. |
Relative efficacies of cannabinoid CB1 receptor agonists in the mouse brain. |
1997 |
Eur. J. Pharmacol. |
pmid:9384246
|
Calignano A et al. |
Potentiation of anandamide hypotension by the transport inhibitor, AM404. |
1997 |
Eur. J. Pharmacol. |
pmid:9389389
|
Begg M et al. |
Modulation of the release of endogenous gamma-aminobutyric acid by cannabinoids in the guinea pig ileum. |
2002 |
Eur. J. Pharmacol. |
pmid:11755170
|
Giuffrida A et al. |
Elevated circulating levels of anandamide after administration of the transport inhibitor, AM404. |
2000 |
Eur. J. Pharmacol. |
pmid:11080522
|
Marichal-Cancino BA et al. |
Analysis of anandamide- and lysophosphatidylinositol-induced inhibition of the vasopressor responses produced by sympathetic stimulation or noradrenaline in pithed rats. |
2013 |
Eur. J. Pharmacol. |
pmid:24076186
|
Wise LE et al. |
Assessment of anandamide's pharmacological effects in mice deficient of both fatty acid amide hydrolase and cannabinoid CB1 receptors. |
2007 |
Eur. J. Pharmacol. |
pmid:17217945
|
Adinolfi B et al. |
Anticancer activity of anandamide in human cutaneous melanoma cells. |
2013 |
Eur. J. Pharmacol. |
pmid:24041928
|
Martin BR et al. |
Assessment of structural commonality between tetrahydrocannabinol and anandamide. |
2002 |
Eur. J. Pharmacol. |
pmid:11790376
|
Kagota S et al. |
2-Arachidonoylglycerol, a candidate of endothelium-derived hyperpolarizing factor. |
2001 |
Eur. J. Pharmacol. |
pmid:11275004
|
Zheng Y et al. |
Dexamethasone alleviates motion sickness in rats in part by enhancing the endocannabinoid system. |
2014 |
Eur. J. Pharmacol. |
pmid:24508383
|
Calignano A et al. |
Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide. |
2001 |
Eur. J. Pharmacol. |
pmid:11426841
|
Lisboa SF et al. |
Activation of cannabinoid CB1 receptors in the dorsolateral periaqueductal gray induces anxiolytic effects in rats submitted to the Vogel conflict test. |
2008 |
Eur. J. Pharmacol. |
pmid:18691568
|
Fride E et al. |
Critical role of the endogenous cannabinoid system in mouse pup suckling and growth. |
2001 |
Eur. J. Pharmacol. |
pmid:11426843
|
Lay L et al. |
Pharmacological characterisation of cannabinoid CB(1) receptors in the rat and mouse. |
2000 |
Eur. J. Pharmacol. |
pmid:10720647
|
Sordelli MS et al. |
Cyclooxygenase-2 prostaglandins mediate anandamide-inhibitory action on nitric oxide synthase activity in the receptive rat uterus. |
2012 |
Eur. J. Pharmacol. |
pmid:22554772
|
Sprague J et al. |
Temperature-dependent activation of recombinant rat vanilloid VR1 receptors expressed in HEK293 cells by capsaicin and anandamide. |
2001 |
Eur. J. Pharmacol. |
pmid:11448475
|
Ndong C et al. |
Cloning and pharmacological characterization of the dog cannabinoid CBâ‚‚receptor. |
2011 |
Eur. J. Pharmacol. |
pmid:21871882
|
Di Marzo V et al. |
Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues. |
2001 |
Eur. J. Pharmacol. |
pmid:11408034
|
Di Marzo V et al. |
Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide. |
2000 |
Eur. J. Pharmacol. |
pmid:11040343
|
Rácz I et al. |
Anandamide effects on 5-HT(3) receptors in vivo. |
2008 |
Eur. J. Pharmacol. |
pmid:18775693
|
Wiley JL et al. |
Evaluation of cannabimimetic effects of structural analogs of anandamide in rats. |
1998 |
Eur. J. Pharmacol. |
pmid:9760024
|
Lichtman AH et al. |
Effects of SR 141716A after acute or chronic cannabinoid administration in dogs. |
1998 |
Eur. J. Pharmacol. |
pmid:9797029
|
Thors L and Fowler CJ |
Effect of nitric oxide donors on membrane tritium accumulation of endocannabinoids and related endogenous lipids. |
2009 |
Eur. J. Pharmacol. |
pmid:19715690
|
Stanley CP et al. |
Cannabinoids alter endothelial function in the Zucker rat model of type 2 diabetes. |
2013 |
Eur. J. Pharmacol. |
pmid:24120371
|
Randall MD and Kendall DA |
Anandamide and endothelium-derived hyperpolarizing factor act via a common vasorelaxant mechanism in rat mesentery. |
1998 |
Eur. J. Pharmacol. |
pmid:9617751
|
Stengel PW et al. |
Inhaled anandamide reduces leukotriene D4-induced airway obstruction in guinea pigs. |
2007 |
Eur. J. Pharmacol. |
pmid:17166495
|
Calignano A et al. |
Inhibition of intestinal motility by anandamide, an endogenous cannabinoid. |
1997 |
Eur. J. Pharmacol. |
pmid:9537804
|
Costa B et al. |
Chronic treatment with the endocannabinoid anandamide increases cytochrome P450 metabolizing system in the rat. |
2002 |
Eur. J. Pharmacol. |
pmid:12163107
|
de Lago E et al. |
UCM707, a potent and selective inhibitor of endocannabinoid uptake, potentiates hypokinetic and antinociceptive effects of anandamide. |
2002 |
Eur. J. Pharmacol. |
pmid:12163112
|
Pertwee RG et al. |
Effect of phenylmethylsulphonyl fluoride on the potency of anandamide as an inhibitor of electrically evoked contractions in two isolated tissue preparations. |
1995 |
Eur. J. Pharmacol. |
pmid:7713152
|
Gratzke C et al. |
Localization and function of cannabinoid receptors in the corpus cavernosum: basis for modulation of nitric oxide synthase nerve activity. |
2010 |
Eur. Urol. |
pmid:19147270
|
Prieto D |
Editorial comment on: localization and function of cannabinoid receptors in the corpus cavernosum: basis for modulation of nitric oxide synthase nerve activity. |
2010 |
Eur. Urol. |
pmid:19147273
|
Wiley JL et al. |
A comparison of the discriminative stimulus effects of delta(9)-tetrahydrocannabinol and O-1812, a potent and metabolically stable anandamide analog, in rats. |
2004 |
Exp Clin Psychopharmacol |
pmid:15301634
|
Burkey RT and Nation JR |
(R)-methanandamide, but not anandamide, substitutes for delta 9-THC in a drug-discrimination procedure. |
1997 |
Exp Clin Psychopharmacol |
pmid:9260067
|
Prestifilippo JP et al. |
Inhibition of salivary secretion by activation of cannabinoid receptors. |
2006 |
Exp. Biol. Med. (Maywood) |
pmid:16946411
|
De Petrocellis L et al. |
Regulation of transient receptor potential channels of melastatin type 8 (TRPM8): effect of cAMP, cannabinoid CB(1) receptors and endovanilloids. |
2007 |
Exp. Cell Res. |
pmid:17428469
|
Frampton G et al. |
Opposing actions of endocannabinoids on cholangiocarcinoma growth is via the differential activation of Notch signaling. |
2010 |
Exp. Cell Res. |
pmid:20347808
|
Grimaldi C et al. |
Anandamide inhibits adhesion and migration of breast cancer cells. |
2006 |
Exp. Cell Res. |
pmid:16343481
|
Jumpertz R et al. |
Circulating endocannabinoids and N-acyl-ethanolamides in patients with sleep apnea--specific role of oleoylethanolamide. |
2010 |
Exp. Clin. Endocrinol. Diabetes |
pmid:20429051
|
Matsuda S et al. |
Metabolism of anandamide, an endogenous cannabinoid receptor ligand, in porcine ocular tissues. |
1997 |
Exp. Eye Res. |
pmid:9245900
|
Köse S et al. |
Human bone marrow mesenchymal stem cells secrete endocannabinoids that stimulate in vitro hematopoietic stem cell migration effectively comparable to beta-adrenergic stimulation. |
2018 |
Exp. Hematol. |
pmid:29030083
|
Venderova K et al. |
Differential effects of endocannabinoids on [(3)H]-GABA uptake in the rat globus pallidus. |
2005 |
Exp. Neurol. |
pmid:15899265
|
Hansen HS |
Palmitoylethanolamide and other anandamide congeners. Proposed role in the diseased brain. |
2010 |
Exp. Neurol. |
pmid:20353771
|
Greco R et al. |
The endocannabinoid system and migraine. |
2010 |
Exp. Neurol. |
pmid:20353780
|
Bhaskaran MD and Smith BN |
Effects of TRPV1 activation on synaptic excitation in the dentate gyrus of a mouse model of temporal lobe epilepsy. |
2010 |
Exp. Neurol. |
pmid:20144892
|
Kreutz S et al. |
Cannabinoids and neuronal damage: differential effects of THC, AEA and 2-AG on activated microglial cells and degenerating neurons in excitotoxically lesioned rat organotypic hippocampal slice cultures. |
2007 |
Exp. Neurol. |
pmid:17010339
|
Bir LS and Ercan S |
Effects of intrathecal anandamide on somatosensory evoked responses in rats. |
2006 |
Exp. Neurol. |
pmid:16289169
|
Solbrig MV et al. |
A role for endocannabinoids in viral-induced dyskinetic and convulsive phenomena. |
2005 |
Exp. Neurol. |
pmid:16022863
|
Morgese MG et al. |
Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: role of CB(1) and TRPV1 receptors. |
2007 |
Exp. Neurol. |
pmid:17900568
|